Morgan Stanley cuts India's GlaxoSmithKline Pharma shares to 'under-weight'
Reuters: Mumbai, Feb 28 2013, 09:08 IST
Morgan Stanley cut its rating on India's GlaxoSmithKline Pharmaceuticals Ltd to "under-weight" from "equal-weight", citing expectations the drug maker will post modest growth and saying margin expansion looked unlikely.
GlaxoSmithKline's shares are also constrained by its pricing policy and "full" valuations, the broker added.
Previous Story Balancing Budget 2013-14 is going to be challenging: Sudhakar Ramasubramanian Next Story Nomura upgrades Wipro shares to 'buy' on growth outlook
Reader's Comments| Post a Comment
Be the first to comment.
